Netherlands · Biotechnology startup
Netherlands · Onward
Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.
Funding reportedLast round: Post ipo debt
What company datasets say Onward raised
Funding, as reported
Reported in all152.3Min the source's currency
Rounds12
Last roundPost ipo debt
Last round dateJun 2024
Investors listed21
Founders and team
From Onward's own website: 11 on the team.
- Dave MarverChief Executive Officer
- Bob OdellVice President, Operations
- Julien CamisaniVice President, Engineering
- Lorenzo FantiVice President, Legal
- Ali KiboroChief Financial Officer
- Sean SciaraChief Commercial Officer
- Shari O’QuinnChief Clinical, Regulatory & Quality Officer
- Alexandre CasteauHead of Strategy & Corporate Development
- Amori FraserSenior Finance Director
- Julie CromDirector, People & Culture
- Rob ten HoedtChairman of the Board
On 4 portfolio pages
Investors who name them
Each firm lists Onward on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
How it ended, so far
Exit
ExitBuyerPriceWhen
Biotechnology in Netherlands
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Onward in front of investors. Or tell us what we have wrong.